Once for Life

Once for Life

Creating transformational gene and peptide therapies that treat the most prevalent diseases to restore health and renew life


Renova Therapeutics envisions a future in which we’re able to permanently treat chronic diseases with gene and peptide therapies. Right now, we’re developing definitive treatments to restore health to people suffering from some of the most common and devastating chronic conditions in the world: congestive heart failure and type 2 diabetes.

Tell Us Who You Are, And We'll Guide You Through our Site

 

Latest News:  September 28, 2017: PRESS RELEASE | 2017 Cell & Gene Meeting on the Mesa featuring Renova Therapeutics CEO & Co-founder as speaker

  September 25, 2017: PRESS RELEASE | Renova Therapeutics leadership speaking at Cell & Gene Therapy CEO forum and Boulder Peptide Symposium

  September 6, 2017: PRESS RELEASE | Renova Therapeutics co-founder awarded highest research honor by the U.S. Department of Veterans Affairs

View All News
Subscribe to receive company press releases and announcements
*required